Akili Inc (AKLI) Quote

SO THIS IS MERGER ????? Virtual Therapeutic Company.

***Yesterday I Received a Letter from T.D.Waterhouse......*** Shareholders has the Choice to Cash $$$ for the Shares they have in their Account - OR- to Keep them and those Shares will be Transfer in the Virtual Therapeutic Company.......❓️❓️❓️The Virtual Therapeutic Trading Price is Not known as of YET???....The Rep. Said They will Notify me......

Happy July4th to all

Best of Luck
janet

👀 AKLI***https://ih.advfn.com/stock-market/USOTC/demand-brands-pk-AKLI/trades

👀***From Barchart.....
https://www.barchart.com/stocks/quotes/AKLI/overview

👀***Link to 72%-
https://www.barchart.com/stocks/quotes/AKLI/opinion

👀***Insider Trading Screener-" Add symbol"......
SecForm4.Com
https://www.secform4.com › insider-trading-screener

👀***.https://nz.finance.yahoo.com ›

👀 ***AKLI NEWS - "Trading Halted"???....

👀Virtual Therapeutics Announces Results of Tender Offer to Acquire Akili Interactive

👀***KIRKLAND, Wash. & BOSTON--(BUSINESS WIRE)-- Virtual Therapeutics, a company focused on improving mental health at scale using engaging, immersive games (“Virtual Therapeutics”), today announced that it has successfully completed the tender offer commenced on June 3, 2024, to acquire all outstanding shares of common stock of Akili, Inc. (Nasdaq: AKLI) (“Akili”) for $0.4340 per share (the “Offer Price”).

***The tender offer expired at one minute after 11:59 p.m. EDT on July 1, 2024 (the “Expiration Date”). As of the Expiration Date, a total of 69,674,538 shares, representing approximately 88.2% of the outstanding shares of common stock of Akili, were validly tendered and not validly withdrawn. The number of shares validly tendered in accordance with the terms of the tender offer and not validly withdrawn satisfied the minimum tender condition, and all other conditions to the tender offer were satisfied. Immediately after the Expiration Date, Virtual Therapeutics irrevocably accepted for payment all shares validly tendered and not validly withdrawn and expects to promptly pay for such shares.

Following completion of the tender offer, Alpha Merger Sub, Inc., a wholly owned subsidiary of Virtual Therapeutics (the “Purchaser”), will promptly merge with and into Akili (the “Merger”). The Merger is expected to occur on July 2, 2024. At the effective time of the Merger, each outstanding share of common stock of Akili that has not been validly tendered (other than shares owned by Akili, by Virtual Therapeutics, the Purchaser, any other subsidiary of Virtual Therapeutics or by any Akili stockholders who properly perfected their appraisal rights under the DGCL) will be converted automatically into the right to receive the Offer Price. As a result of the Merger, Akili will become a wholly owned subsidiary of Virtual Therapeutics.

Prior to the opening of trading on The Nasdaq Stock Market LLC (“Nasdaq”) on July 2, 2024, all shares of Akili common stock ceased trading on Nasdaq, and Virtual Therapeutics intends promptly to cause such shares to be delisted from Nasdaq and deregistered under the Securities Exchange Act of 1934, as amended.

“The completion of this acquisition provides a foundation for us to build a leading digital health company that is capable of bringing new behavioral services to as many patients as possible,” said Dan Elenbaas, co-founder and CEO of Virtual Therapeutics. “We look forward to leveraging Akili’s expertise and strengths as we embark on this next stage of growth for Virtual Therapeutics.”

Advisors

TD Cowen is acting as exclusive financial advisor and Goodwin Procter LLP is acting as legal counsel to Akili. Baker & McKenzie LLP is acting as legal counsel to Virtual Therapeutics.

About Akili

Akili is pioneering the development of cognitive treatments through game-changing technologies. Akili’s approach of leveraging technologies designed to directly target the brain establishes a new category of medicine – medicine that is validated through clinical trials like a drug or medical device but experienced like entertainment. Akili’s platform is powered by proprietary therapeutic engines designed to target cognitive impairment at its source in the brain, informed by decades of research and validated through rigorous clinical programs. Driven by Akili’s belief that effective medicine can also be fun and engaging, Akili’s products are delivered through captivating action video game experiences.

About Virtual Therapeutics

Virtual Therapeutics is a digital health company delivering scalable, accessible, affordable, and personalized solutions for mental health and mental fitness. Leveraging extensive expertise as game developers, the company crafts and curates rich, appealing experiences that combine proven therapeutic techniques with modern gameplay mechanisms to delight and engage users. Virtual Therapeutics uses powerful cloud-based platform to gather and analyze various data streams to continuously measure, validate, and report effectiveness, seamlessly deploy and maintain its solutions, and provide users and partners with a truly turnkey experience. For more information, visit https://www.vthera.com/.

Forward-looking Statements

This communication contains “forward-looking statements” relating to the acquisition of Akili by Virtual Therapeutics. Such forward-looking statements include, but are not limited to, statements regarding the payment and timing of payment of the Offer Price to former Akili stockholders and the ability and timing of delisting of Akili’s common stock. Actual events or results may differ materially from these forward-looking statements. Words such as “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “future,” “opportunity” “will likely result,” “target,” variations of such words, and similar expressions or negatives of these words are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words.

Forward-looking statements are neither historical facts nor assurances of future performance and involve risks and uncertainties that could cause actual results to differ materially from those projected, expressed or implied by such forward-looking statements. Although Virtual Therapeutics and Akili believe that the expectations reflected in such forward-looking statements are reasonable, they cannot guarantee future events, results, actions, levels of activity, performance or achievements, business and market conditions and the timing and results of any developments. Additional factors that may affect the future results of Akili are set forth in Akili’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including Akili’s most recently filed Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the SEC, which are available on the SEC’s website at www.sec.gov. As a result of such risks and uncertainties, actual results may differ materially from any future results, performance or achievements discussed in or implied by the forward-looking statements contained herein. The forward-looking statements in this press release are subject to a number of risks and uncertainties, including, but not limited to, the risk that the timing of the payment or delisting may be delayed. Virtual Therapeutics and Akili caution investors not to unduly rely on any forward-looking statements.

The forward-looking statements contained in this release are made as of the date hereof, and Virtual Therapeutics and Akili undertake no obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise, except as expressly required by law. All forward-looking statements in this document are qualified in their entirety by this cautionary statement.

https://cts.businesswire.com/ct/CT?id=bwnews&sty=20240701029834r1&sid=acqr8&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20240701029834/en/

Ian Stone, Inizio Evoke Communications
ian.stone@inizioevoke.com
619-518-3518

👀***Source: Virtual Therapeutics

👀***OTC Markets
https://www.otcmarkets.com

👀***Akili (AKLI) Stock Forecast and Price Target 2024

👀***MarketBeat
https://www.marketbeat.com ›
·
👀***AKLI's current price target is $4.00. Learn why top analysts are making this stock forecast for Akili at MarketBeat.

FROM: MarketBeat: Akili (AKLI) Stock Price, News & Analysis

***Akili (AKLI) Stock Forecast & Price Target

Type: Akili Medical Companies S&P 500

***AKLI Consensus Rating Score vs. The Competition

..................................................3.00 ...................................2.71.......................................2.50............
Consensus Rating:.................. BUY.................................MODERATE BUY...................MODERATE BUY
***Predicted Upside..................820.17% Upside.............804.56% Upside.....................11.46% Upside
***News Sentiment Rating........Positive News.................Positive News.........................Positive News

About Akili Stock (NASDAQ:AKLI)
Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company was founded in 2011 and is headquartered in Boston, Massachusetts.

👀 AKLI***https://ih.advfn.com/stock-market/USOTC/demand-brands-pk-AKLI/trades

👀***From Barchart.....
https://www.barchart.com/stocks/quotes/AKLI/overview

👀***Link to 72%-
https://www.barchart.com/stocks/quotes/AKLI/opinion

👀***Insider Trading Screener-" Add symbol"......
SecForm4.Com
https://www.secform4.com › insider-trading-screener

👀***.https://nz.finance.yahoo.com ›

AKLI - Strange Trading Going on....

👀***From Barchart.....
https://www.barchart.com/stocks/quotes/AKLI/overview

👀***Link to 72%-
https://www.barchart.com/stocks/quotes/AKLI/opinion

👀***Insider Trading Screener-" Add symbol"......
SecForm4.Com
https://www.secform4.com › insider-trading-screener

👀***.https://nz.finance.yahoo.com ›

AKLI - I received this e-mal about AKLI ......

***Akli Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game

***.https://nz.finance.yahoo.com ›

AKLI: Thanks for the heads-up!! (Nice merger news.)

$AKLI NEWS https://ih.advfn.com/stock-market/NASDAQ/akili-AKLI/stock-news/93941876/virtual-therapeutics-akili-interactive-enter-into

And down, down, again. What a rollercoaster. Many going to get stuck again for some time. LOL

Worth more dead than alive

Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results

I never buy PM or AH

The price always changes throughout the course of the day. I like this company and the fact that institutions like it.

AKLI https://www.benzinga.com/premarket

Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan

AKLI new 52 week low

AKLI new 52=week low

AKLI new 52 week low

AKLI new 52 week low

Going to zero

AKLI new 52 week low

AKLI new 52 week low

AKLI new 52 week low

Hmmm see ya 2.28

Chart is good right now

Hmmm flashes of 1.88

Little boomage happening

Filled

1.37

Added some here

Ah Da let's be a moron and sell 10 little punk shares at $1.61, after hours,when it was trading at $1.80 right before the close, stupid little manipulator.

Nice news. Heavy buying. Little PPS movement. Dilution on news perhaps. Watch.

AKLI

Be very careful naked shorters,you have moved higher up on the list,of over shorted over sold stocks,with high potential for a short squeeze on more than just a few social media trading sites and blogs,with more than just a few large investment funds recently buying large amounts of shares,sooner or later they are going to move it much higher off these levels and blow up short positions.

Naked shorts and those "air shares" are disappearing

Bear shares are running quite thin today.

3 days oversold and 31 RSI

Just by looking at the daily share price it's clear that shorts are getting trapped.
From red to green then green to red throughout the day and a slowly rising bottom share price they're quickly running out of invisible "Air Shares"

This is so annoying for us Bulls though it makes it nice to pick up more cheap shares.

The highs and lows are narrowing more daily and volume has almost completely dried up with just 633,000 traded today. The lowest volume traded in one day for Akili.

Any news or even a share update from one of their recent major investors will send this flying.

The noose is very tight for shorts now.

Red day then green days. It looks like bears and bulls fighting back and forth
for a few days.

Boatloads of naked shorts have piled on wherever they're coming from. ??
Maybe it's Dark Pool manipulation though the volume in Dark Pool isn't very much.

The share price is way too low.

If we get good sales #s from the Roblox partnership then I'm pretty sure Roblox will be buying up shares and then it will likely explode back over $40

That would be a wild ride if those targets got hit or even close to them,many selling fools would have many tears.

Naked Calls? Is this possible with Akili shares?

I'm reading the Fidelity website where they're talking about uncovered Calls that are Bets placed on bearish sentiment.

In my view on this..it just sounds like more dark pool trading. Is it possible when there's no Put options available?

That's interesting though. Now I'm looking at past investments I've had that I expect would be much higher such as Vroom and Bionano that ARE shortable

I'm changing my investment strategy based upon that finding. I'll place a bigger risk assessment on stock with both Put/Call options

You're correct. Akili isn't shortable

Calls only according to Finviz. This is really nice since it means we'll see a much
higher share price in the future.
I believe $30 to $50 in the next few months is reasonable.

The Shadyside pros are scm bags all day long, their game plan is to rip off anyone who gets in their way,and to do it in anyway possible or in any direction they feel like, with no fear of the SEC who let's them get away with it,I very rarely trade on margin,only in my futures account where you kind of have to,unless you have a large capitalized account.

This one has seen a large amount of corrupt manipulation since day one, the open option Int is much higher on the calls side compared to the puts, I'm not sure if options chains were listed here,from when it first started trading, there could be a large amount of calls sold short and written just waiting for a big squeeze.

It's taken a handful of Billionaire investors just to stabilize Akili stock...
and that's with a smaller. Float of about 85 million

People trading in Dark Pool, Puts and secondary IPOs listed on the major exchanges should get jail time.
Those that use Margin Accounts shouldn't be trading. Even if you do very well on Margin Account I strongly believe a person's skills are better utilized with cash trades.

Just for a Recap: options traders commonly buy up Calls when there's very little retail buying but then purchase Puts heavily on any good news to trick retail into selling.

I hate people, or businesses that do these shady trade practices.

As fools sell for small fry chump change profits, more large hedge funds are adding more shares,they know a bargain when they see one, as the clueless over night Flipbags can't see beyond their beer bellies.

Pure Tech inside buy 10% holding

1 Week Haramis next



Bullish Harami Cross

Harami Cross Enhancers

For a bullish harami cross, some traders may act on the pattern as it forms, while others will wait for confirmation. Confirmation is a price move higher following the pattern. In addition to confirmation, traders may also give a bullish harami cross more weight or significance if it occurs at a major support level. If it does, there is a greater chance of a larger price move to the upside, especially if there is no nearby resistance overhead.

Traders may also watch other technical indicators, such as the relative strength index (RSI) moving up from oversold territory, or confirmation of a move higher from other indicators